Proteostasis Therapeutics, Inc. (PTI) Social Stream

Proteostasis Therapeutics, Inc. (PTI)

Today's Latest Price: $1.01 USD

0.01 (-0.98%)

Updated Nov 24 6:55pm

Add PTI to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

Featured Post From StockTwits About PTI

$PTI People Losing money for no reason.
Yumanity Therapeutics raised more than $100M with the support of Fidelity Management & Research, Redmile Group, Alexandria Venture Investments, Biogen, Pfizer, Sanofi Ventures, Dolby Family Ventures, Longevity, and Merck & Co. to accelerate the discovery and development of novel therapies in neurodegenerative diseases. In addition, the Company has an ongoing strategic research collaboration focused on accelerating developing of new treatments for neurodegenerative diseases, for which Yumanity received an upfront payment and is eligible to receive milestone payments totaling approximately $500 million as well as royalties on net sales.,
cif, published November 24, 2020

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7623 seconds.